1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. ORGENESIS INC
Orgenesis Inc XNAS: ORGS

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Orgenesis Inc is on 16 Jul 2025 for the purpose of Orgenesis Inc First Quarter Earnings Results for 2025 See details


Insider Trading disclosures for Orgenesis Inc

The latest disclosure was made by Adam Pelavin in Orgenesis Inc where a trade of 625 Stock Option done was reported to US exchanges on Dec. 12, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Adam Pelavin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 625 625 - - Stock Option
Adam Pelavin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 1,250 1,250 - - Stock Option
Santhosh Nagaraj Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 1,250 1,250 - - Stock Option
Santhosh Nagaraj Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 625 625 - - Stock Option
Jagannathan Bhalaji Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 625 625 - - Stock Option
Jagannathan Bhalaji Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 1,250 1,250 - - Stock Option
Itzhak Vider Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 1,500 1,500 - - Stock Option
Ashish Nanda Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 1,835 1,835 - - Stock Option
Yaron Adler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 1,750 1,750 - - Stock Option
Ashish Nanda Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2024 189,320 189,320 - - Stock Option (Right to Buy)
Ashish Nanda Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2024 189,320 189,320 - - Stock Option (Right to Buy)
Vered Caplan Director, CEO & CHAIRMAN OF THE BOARD Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2024 85,000 85,000 - - Stock Option (Right to Buy)
Itzhak Vider Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jul 2024 6,250 6,250 - - Stock Option (Right to Buy)
Mark Goodman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2024 6,250 6,250 - - Stock Option (Right to Buy)
Victor Miller CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2024 200,000 200,000 - - Stock Option (Right to Buy)
Victor Miller Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2024 25,000 175,000 - - Stock Option (Right to Buy)
Victor Miller Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.50 per share. 01 Apr 2024 25,000 25,000 (0%) 0% 0.5 12,500 Common Stock
Miller Victor CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 200,000 200,000 - - Stock Option (Right to Buy)
Nanda Ashish Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2023 15,850 15,850 - - Stock Option
Philips Mario Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2023 13,750 13,750 - - Stock Option
Guy Yachin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2023 19,600 19,600 - - Stock Option
Sidransky David Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2023 20,450 20,450 - - Stock Option
Yaron Adler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2023 15,000 15,000 - - Stock Option
Ashish Nanda Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2022 15,850 15,850 - - Stock Option
Guy Yachin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2022 19,600 19,600 - - Stock Option
Mario Philips Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2022 13,750 13,750 - - Stock Option
David Sidransky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2022 20,450 20,450 - - Stock Option
Yaron Adler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2022 15,000 15,000 - - Stock Option
Neil Reithinger CFO, Treasurer and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 15,000 15,000 - - Stock Option
Vered Caplan Director, CEO and Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 85,000 85,000 - - Stock Option
Efrat Assa Kunik Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 15,000 15,000 - - Stock Option
Vered Caplan Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jan 2022 278,191 0 - - Stock Option (Right to Buy)
Vered Caplan Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.01 per share. 28 Jan 2022 278,191 278,191 (1%) 1% 0.0 3,338 Common Stock
Neil Reithinger CFO, Treasurer and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2020 15,000 15,000 - - Stock Option
David Sidransky None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2020 12,500 12,500 - - Stock Option
Vered Caplan Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2020 85,000 85,000 - - Stock Option
Yaron Adler None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2020 12,500 12,500 - - Stock Option
Mario Philips None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2020 12,500 12,500 - - Stock Option
Guy Yachin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2020 12,500 12,500 - - Stock Option
Ashish Nanda None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2020 12,500 12,500 - - Stock Option
Sarah Ferber Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2020 3,750 3,750 - - Stock Option
Mario Philips None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2020 6,250 6,250 - - Stock Option
Ashish Nanda Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2019 12,500 12,500 - - Stock Option
Guy Yachin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2019 12,500 12,500 - - Stock Option
Yaron Adler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2019 12,500 12,500 - - Stock Option
David Sidransky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2019 12,500 12,500 - - Stock Option
David Sidransky None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2018 29,200 29,200 - - Stock Option
Vered Caplan Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2018 85,000 85,000 - - Stock Option
Ashish Nanda None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2018 27,100 27,100 - - Stock Option
Guy Yachin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2018 28,750 28,750 - - Stock Option
Sarah Ferber Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2018 3,750 3,750 - - Stock Option
Yaron Adler None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2018 28,750 28,750 - - Stock Option
Vered Caplan CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2018 250,000 250,000 - - Stock Option (Right to Buy Common Stock)
Denis Bedoret See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2018 15,000 15,000 - - Stock Option
David Sidransky None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jul 2013 20,834 20,834 - - Stock Option
Etti Hanochi None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Aug 2012 235,630 235,630 - - Stock Options
Vered Caplan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jul 2012 3,338,285 3,338,285 - - Stock Options
Yaron Adler None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jul 2012 706,890 706,890 - - Stock Options
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters